The present invention relates to prosthetic valves and methods for their implantation. More particularly, the present invention provides for prosthetic valve support structures configured for transcatheter delivery.
Aortic valve replacement in patients with severe valve disease is a common surgical procedure. The replacement is conventionally performed by open heart surgery, in which the heart is usually arrested and the patient is placed on a heart bypass machine. Prostheses including prosthetic heart valves have been developed that are implanted using minimally invasive procedures such as transapical or percutaneous approaches. These methods involve compressing the prosthesis radially to reduce its diameter, inserting the prosthesis into a delivery tool, such as a catheter, and advancing the delivery tool to the correct anatomical position in the heart. Once properly positioned, the prosthesis is deployed by radial expansion within the native valve annulus.
Such a prosthesis can include a support structure to maintain the prosthetic heart valve in place. The inflow section of the prosthesis can be subject to radial interference from a body lumen, such as the left ventricular outflow tract (LVOT), that can exert circumferential radial pressure on the prosthesis. Such radial interference at an inflow section of the prosthesis can result in radial movement at an outflow section of the prosthesis. Such movement may be undesirable.
Moreover, a prosthesis can be subject to radial movement at an inflow section, due to, for example, valve function and cardiac contraction. Such radial movement can cause the diameter of the inflow section to experience cyclical contraction and expansion. Such contraction and expansion can subject the prosthesis to unnecessary fatigue.
Additionally, due to less than perfect conformance between the geometries of a patient's anatomy and the prosthesis, paravalvular leakage can occur. For example, a major course of leakage between a prosthesis and the LVOT wall is due to spaces created between scalloped leaflets called inter-leaflet triangles.
Accordingly, there is a need for a prosthesis that provides decoupled radial motion of the outflow section and the inflow section, and that better conforms to a patient's anatomy.
PCT Publication No. WO 05/002466 to Schwammenthal et al., which is incorporated herein by reference in its entirety, describes prosthetic devices for treating aortic stenosis.
PCT Publication No. WO 06/070372 to Schwammenthal et al., which is incorporated herein by reference in its entirety, describes a prosthetic device having a single flow field therethrough, adapted for implantation in a subject, and shaped so as to define a fluid inlet, and a diverging section, distal to the fluid inlet.
US Patent Application Publication No. 2006/0149360 to Schwammenthal et al., which is incorporated herein by reference in its entirety, describes a prosthetic device including a valve-orifice attachment member attachable to a valve in a blood vessel and including a fluid inlet, and a diverging member that extends from the fluid inlet, the diverging member including a proximal end near the fluid inlet and a distal end distanced from the proximal end. A distal portion of the diverging member has a larger cross-sectional area for fluid flow therethrough than a proximal portion thereof.
US Patent Application Publication No. 2006/0259136 to Nguyen et al., which is incorporated herein by reference, describes a heart valve prosthesis having a self-expanding multi-level frame that supports a valve body including a skirt and plurality of coapting leaflets. The frame transitions between a contracted delivery configuration that enables percutaneous transluminal delivery, and an expanded deployed configuration having an asymmetric hourglass shape. The valve body skirt and leaflets are constructed so that the center of coaptation can be selected to reduce horizontal forces applied to the commissures of the valve, and to efficiently distribute and transmit forces along the leaflets and to the frame. Alternatively, the valve body can be used as a surgically implantable replacement valve prosthesis.
The present invention provides a valve prosthesis support structure that limits radial motion at a distal end thereof.
The present invention also provides a valve prosthesis support structure that limits radial motion at a proximal end thereof.
The present invention also provides a valve prosthesis support structure that includes sealing members to prevent paravalvular leakage.
The present invention provides a prosthesis including a support structure having a proximal end and a distal end, and a motion limiting member attached to the distal end of the support structure, wherein the motion limiting member is configured to restrict radial expansion of the distal end of the support structure.
The present invention also provides a valve prosthesis support structure, including a collapsible and expandable support structure including a plurality of posts at a distal end thereof and a flared portion extending in a proximal direction from the plurality of posts, and a motion limiting member attached to a proximal end of the proximal skirt, wherein the motion limiting member is configured to restrict radial movement of the proximal end of the collapsible support structure.
The present invention also provides a method of delivering a prosthesis to a desired location in a body. One such method includes introducing a sheath of a delivery system into a subject's vasculature, wherein a distal tip of the sheath contains the prosthesis, advancing the distal tip of the sheath to the desired location in the body, and releasing the prosthesis within the body, wherein the prosthesis includes a support structure having a proximal end and a distal end, and a motion limiting member attached to the distal end of the support structure.
Additional features of the invention will be set forth in the description that follows. Both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.
The accompanying figures, which are incorporated herein, form part of the specification and illustrate exemplary embodiments of the present invention. Together with the description, the figures further serve to explain the principles of and to enable a person skilled in the relevant art(s) to make and use the exemplary embodiments described herein. In the drawings like reference characters indicate identical or functionally similar elements.
The following detailed description of the present invention refers to the accompanying figures that illustrate exemplary embodiments. Other embodiments are possible and may fall within the scope of the present invention. Modifications can be made to the exemplary embodiments described herein without departing from the spirit and scope of the present invention. Therefore, the following detailed description is not meant to be limiting. The operation and behavior of the exemplary embodiments presented are described with the understanding that various modifications and variations of the exemplary embodiments may be within the scope of the present invention.
Valve prosthesis support structure 130 includes posts 122 (also referred to as commissural posts) proximate to outflow section 120, and a proximal skirt 132 extending from inflow section 110 toward posts 122.
Valve prosthesis 100 is preferably collapsible in order to facilitate transcatheter delivery. Preferably, valve prosthesis 100 can be delivered via a transfemoral approach. Valve prosthesis 100 can also be delivered, however, by other transvascular approach methods or a transapical approach. Valve prosthesis 100 can also be implanted by open heart surgery or related methods. The valve prosthesis 100 can expand radially upon delivery at a target site. The target site is preferably the native aortic annulus of a subject, but it is understood that valves according to the present invention could be implanted at other positions in a subject (e.g., a native mitral or pulmonary annulus).
For example, distal tip of a catheter sheath containing prosthesis 100 can be inserted into a patient's vasculature (e.g., via a body lumen such as a femoral artery) and advanced (along a guide wire, if provided) to the position of a native annulus. The native leaflets of the annulus can be in place at the time of implantation of prosthesis 100, or can be partially or completely removed prior to implantation. An outer tube of the catheter can be withdrawn some distance to expose a proximal portion of proximal skirt 132. The proximal portion can be positioned so as to abut against the ventricular side of the aortic annulus. If provided, barbs 134 can be primary contact points of prosthesis 100 with an interior of a valve retaining sleeve, thereby reducing friction that could be caused by the inner surface of the valve retaining sleeve sliding over prosthesis 100 while prosthesis 100 moves with respect to the catheter sheath. Once it is determined that prosthesis 100 is properly positioned in the annulus, the outer tube can be fully withdrawn, releasing valve prosthesis 100 and allowing radial expansion of valve prosthesis 100 to engage the annulus. If, after partial release, it is determined that the prosthesis is not properly positioned, the inflow section 110 can be recaptured into the outer tube for repositioning.
Prosthesis support structure 130 can be made of a self-expanding material, e.g., nitinol, thus tending toward a fully expanded position that is sufficient to securely engage the native annulus. When in position within a patient, this tendency creates a radial force between prosthesis support structure 130 and the patient's anatomy, thus helping to hold valve prosthesis 100 in place. The pressure applied by the prosthesis support structure 130, however, need not be sufficient by itself to anchor the prosthesis 100 in the native annulus. Further inhibiting migration of valve prosthesis 100 can be axial support arms 128, which protrude over the tips of the native leaflets to provide axial support to valve prosthesis 100 and to prevent valve prosthesis 100 from being forced into the ventricle through the native leaflets during the cardiac cycle. Support arms 128 can take on a variety of configurations. Further, as detailed above, inflow section 110 can engage the ventricle below the inflow end of the native annulus, providing additional anchoring.
Support arms 128 can, for example, be configured to be at least partially disposed within aortic sinuses of the subject, and, for some applications, to engage and/or rest against floors of the aortic sinuses, and to apply an axial force directed toward a left ventricle of the subject. Support arms 128 can meet one another at junctures. For applications in which each of support arms 128 is fabricated as a separate piece, the support arms can be mechanically engaged to one another where they meet at the junctures. For some applications, support arms 128 meet one another without actually touching one another, and instead meet via an area defined at each juncture. Typically, the support arms are configured to define peaks at the junctures, and troughs between adjacent peaks. U.S. application Ser. No. 11/728,253, filed Mar. 23, 2007, and U.S. application Ser. No. 11/726,889, filed Mar. 23, 2007 detail various support arm configurations, and each is incorporated by reference herein in its entirety.
In some exemplary embodiments, valve prosthesis 100 includes three posts 122, arranged circumferentially around a central longitudinal axis of valve prosthesis 100, and a flared portion extending in a proximal direction from posts 122. In some exemplary embodiments, valve prosthesis 100 includes more or fewer than three posts 122, such as, for example, two posts 122, or four posts 122. Approximately 90% of humans have exactly three aortic sinuses. The three posts 122 provided in some exemplary embodiments correspond to these three aortic sinuses. For implantation in the approximately 10% of patients that have exactly two aortic sinuses, valve prosthesis 100 can include only two posts 122.
Valve prosthesis 100 can also include a valve 150 coupled to posts 122. Valve 150 can be formed of a pliant material configured to collapse inwardly (i.e., towards the central longitudinal axis of valve prosthesis 100) during diastole, in order to inhibit retrograde blood flow, and to open outwardly during systole, to allow blood flow through valve prosthesis 100. Valve 150 can be formed of artificial or natural tissue. For example, valve 150 can be formed of bovine or porcine pericardium, or of any suitable synthetic material.
Decoupling of radial motion of outflow section 120 from radial interference at inflow section 110 can produce significant benefits by providing more predictable and stable valve geometry regardless of patient-specific anatomy.
Valve prosthesis 300 further includes a motion limiting member 324. Motion limiting member 324 includes a substantially rigid circular frame disposed around outflow section 320. The substantially rigid circular frame preferably substantially maintains its shape even when subjected to outside forces such as can be present within a body lumen of a patient. The substantially rigid circular frame can be made of, for example, the types of surgical steel traditionally used for making stent devices. Motion limiting member 324 can be mounted to valve prosthesis support structure 330 by being attached to distal ends of posts 322. In such a configuration, motion limiting member 324 prevents divergence of posts 322 by limiting the maximum diameter of outflow section 320, thereby preventing motion of posts 322 beyond the limits imposed by motion limiting member 324. Motion limiting member 324 can be constructed of a variety of materials, for example, nitinol.
The rigid circular frame of motion limiting member 324 can, however, be sufficiently flexible to be compatible with collapse of valve prosthesis 300 during an insertion process.
The rigid circular frame of motion limiting member 324 can alternately or additionally be mounted to valve prosthesis support structure 330 by being attached to proximal ends of posts 322, or at intermediate positions of posts 322, in between proximal and distal ends.
Because the diameter of outflow section 320 is limited by motion limiting member 324, the diameter of outflow section 320 is not substantially affected by changes in the diameter of inflow section 310, thereby decoupling radial motion of outflow section 320 from radial interference at inflow section 310. Thus, valve prosthesis 300 maintains predictable and stable valve geometry regardless of patient-specific anatomy.
Valve prosthesis 500 includes an inflow section 510 at a proximal end thereof, and an outflow section 520 at a distal end thereof. Valve prosthesis 500 also includes a valve prosthesis support structure 530, and a motion limiting member 524. Valve prosthesis support structure 530 includes posts 522 proximate to outflow section 520, and a proximal skirt 532 extending from inflow section 510 toward posts 522.
Motion limiting member 524 includes rigid arches disposed proximate to outflow section 520. Each rigid arch is mounted to valve prosthesis support structure 530 by being attached to proximal ends of two adjacent posts 522. In this way, the rigid arches of the motion limiting member 524 together extend around outflow section 520. In such a configuration, motion limiting member 524 prevents divergence of posts 522 by limiting the diameter of outflow section 520, thereby preventing motion of posts 522 beyond the limits imposed by motion limiting member 524.
In some embodiments, the rigid arches of motion limiting member 524 can together form a circular shape, or can form another shape, such as, for example, a series of linked “humps” connecting around outflow section 520.
In some embodiments, the rigid arches of motion limiting member 524 are sufficiently flexible to collapse with valve prosthesis 500 during an insertion process.
In some embodiments, the rigid arches of motion limiting member 524 are mounted to valve prosthesis support structure 530 by being attached to distal ends of posts 522, or at intermediate positions of posts 522, in between proximal and distal ends.
In some embodiments, the rigid arches of motion limiting member 524 can extend out from valve prosthesis support structure 530 at a 90 degree angle with respect to a longitudinal axis extending through valve prosthesis 500. Alternatively, the rigid arches of motion limiting member 524 can extend from valve prosthesis support structure 530 at an angle other than 90 degrees, such as, for example, approximately 30 degrees, approximately 45 degrees, or approximately 120 degrees. Moreover, each rigid arch need not extend out from valve prosthesis support structure 530 at the same angle as other rigid arches.
In some embodiments multiple rigid arches can extend between adjacent posts 522. Intermediate connections can be formed between adjacent rigid arches such that the rigid arches extending between adjacent posts 522 are connected in series.
Because the diameter of outflow section 520 is limited by motion limiting member 524, it is not substantially affected by radial interference (i.e., changes in diameter) at inflow section 510, thereby achieving decoupling of radial motion of outflow section 520 from radial interference at inflow section 510. Thus, valve prosthesis 500 maintains predictable and stable valve geometry regardless of patient-specific anatomy.
Valve prosthesis 700 includes an inflow section 710 at a proximal end thereof, and an outflow section 720 at a distal end thereof. Valve prosthesis 700 also includes a valve prosthesis support structure 730, and a motion limiting member 724.
Valve prosthesis support structure 730 includes posts 722 proximate to outflow section 720, and a proximal skirt 732 extending from posts 722 toward inflow section 710.
Motion limiting member 724 includes linear support elements disposed proximate to outflow section 720. Each linear support element is mounted to valve prosthesis support structure 730 by being attached to distal ends of two adjacent posts 722. In this way, the linear support elements of motion limiting member 724 together link posts 722. In such a configuration, motion limiting member 724 prevents divergence of posts 722 by limiting the diameter of outflow section 720, thereby preventing motion of posts 722 beyond the limits imposed by motion limiting member 724.
In some embodiments the linear support elements of motion limiting member 724 are non-rigid and act only in tension. For example, such linear support elements can be made of string, wire, sutures, or the like.
In some embodiments, the linear support elements of motion limiting member 724 are rigid.
In some embodiments, the linear support elements of motion limiting member 724 are mounted to valve prosthesis support structure 730 by being attached to proximal ends of posts 722, or at intermediate positions of posts 722, in between proximal and distal ends.
In some embodiments multiple linear support sub-elements can extend between adjacent posts 722, with intermediate connections between adjacent linear support sub-elements such that the linear support sub-elements extending between adjacent posts 722 are connected in series.
Because the diameter of outflow section 720 is limited by motion limiting member 724, it is preferably not substantially affected by radial interference (i.e., changes in diameter) at inflow section 710, thereby achieving decoupling of radial motion of outflow section 720 from radial interference at inflow section 710. Thus, valve prosthesis 700 maintains predictable and stable valve geometry regardless of patient-specific anatomy.
Valve prosthesis 900 includes an inflow section 910 at a proximal end thereof, and an outflow section 920 at a distal end thereof. Valve prosthesis 900 also includes a valve prosthesis support structure 930, and a motion limiting member 926.
Valve prosthesis support structure 930 includes posts 922 proximate to outflow section 920, and a proximal skirt 932 extending from inflow section 910 toward posts 922.
Motion limiting member 926 includes strut support elements disposed proximate to inflow section 910. Each strut support element is mounted to a proximal end of inflow section 910, and extends between adjacent endpoints of proximal skirt 932. In this way, the strut support elements of motion limiting member 926 together link endpoints of inflow section 910. In such a configuration, motion limiting member 926 prevents divergence of the endpoints of proximal skirt 932 by limiting the diameter of inflow section 910, thereby preventing motion of the endpoints of proximal skirt 932 beyond the limits imposed by motion limiting member 926.
In some embodiments, multiple strut support elements can extend between adjacent endpoints of proximal skirt 932, with intermediate connections between adjacent endpoints of proximal skirt 932 such that the strut support elements extending between adjacent endpoints of proximal skirt 932 are connected in series.
In some embodiments, the strut support members of motion limiting member 926 are incorporated in and form a part of proximal skirt 932 such that motion limiting member 926 and proximal skirt 932 are formed together monolithically.
In some embodiments, the strut support members of motion limiting member 926 are rigid. In some embodiments, the strut support members of motion limiting member are non-rigid.
Because the diameter of inflow section 910 is limited by motion limiting member 926, its motion due to valve function and cardiac contraction can be confined to within limits necessary for proper functioning, thereby eliminating or reducing unnecessary radial movement. Reducing this unnecessary radial movement in turn reduces the fatigue that valve prosthesis 900 is subject to, thereby extending its useful life, and eliminating the need for subsequent replacement of valve prosthesis 900 or reducing the frequency with which valve prosthesis 900 must be replaced to maintain proper functionality. Additionally, because motion limiting member 926 limits the diameter of inflow section 910, valve prosthesis 900 maintains more predictable and stable valve motion and valve geometry regardless of patient-specific anatomy. Further, stabilizing the diameter of inflow section 910 results in less deformation (i.e., changes in diameter) of outflow section 920.
Valve prosthesis 1100 includes an inflow section 1110 at a proximal end thereof, and an outflow section 1120 at a distal end thereof. Valve prosthesis 1100 also includes a valve prosthesis support structure 1130, and sealing members 1142.
Valve prosthesis support structure 1130 includes posts 1122 proximate to outflow section 1120, and a proximal skirt 1132 extending from posts 1122 toward inflow section 1110.
Sealing members 1142 can be disposed proximate to inflow section 1110, and can be positioned to correspond radially with posts 1122. Such positioning corresponds to native commissures, and aligns sealing members 1142 with a patient's inter-leaflet triangles. Sealing members 1142 can be shaped so as to fit into the inter-leaflet triangles, or can be formed of a material that conforms to the shape of the inter-leaflet triangles upon being placed in contact with the inter-leaflet triangles. In this way, sealing members 1142 help valve prosthesis 1100 attain a high level of conformance to the patient's annular anatomy, thereby preventing or reducing the chance and severity of paravalvular leakage. U.S. application Ser. No. 13/091,765, filed Apr. 21, 2011, discusses sealing members for use with prosthetic valves, and is incorporated by reference herein in its entirety.
Valve prosthesis 1200 includes an inflow section 1210 at a proximal end thereof, and an outflow section 1220 at a distal end thereof. Valve prosthesis 1200 also includes a valve prosthesis support structure 1230, and a sealing member 1242.
Valve prosthesis support structure 1230 includes posts 1222 proximate to outflow section 1220, and a proximal skirt 1232 extending from posts 1222 toward inflow section 1210.
Sealing member 1242 can be disposed proximate to inflow section 1210, and can extend around the circumference of proximal skirt 1232. Sealing member 1242 can include sealing tips 1244 positioned to correspond radially with posts 1222. Such positioning corresponds to native commissures, and aligns sealing tips 1244 with a patient's inter-leaflet triangles. Sealing tips 1244 can be shaped so as to fit into the inter-leaflet triangles, or can be formed of a material that conforms to the shape of the inter-leaflet triangles upon being placed in contact with the inter-leaflet triangles. In this way, sealing member 1242, including sealing tips 1244, helps valve prosthesis 1200 attain a high level of conformance to the patient's annular anatomy, thereby preventing or reducing the chance and severity of paravalvular leakage.
In some embodiments, sealing member 1242 including sealing tips 1244 is formed of a single material. In some embodiments, sealing tips 1244 are formed of a material different from the balance of sealing member 1242. For example, sealing tips 1244 can be faulted of a soft material capable of conforming to the patient's inter-leaflet triangles, while the balance of sealing member 1242 can be formed of a more rigid material.
In some embodiments, sealing member 1242 acts as a motion limiting member, and limits the diameter of inflow section 1210, thereby preventing motion of endpoints of proximal skirt 1232 beyond limits imposed by sealing member 1242. In this way, sealing member 1242 is similar to motion limiting member 926.
While various embodiments of the present invention have been described above, they have been presented by way of example only, and not limitation. The elements of the embodiments presented above are not necessarily mutually exclusive, but can be interchanged to meet various needs as would be appreciated by one of skill in the art.
It therefore will be apparent to one skilled in the art that various changes in form and detail can be made to the embodiments disclosed herein without departing from the spirit and scope of the present invention. The phraseology or terminology herein is used for description and not for limitation. Thus, it is intended that the present invention cover modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.
This application is a divisional of U.S. patent application Ser. No. 13/216,533, filed Aug. 24, 2011, which claims priority to U.S. Provisional Patent Application No. 61/379,115, filed Sep. 1, 2010, both of which are incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
3795246 | Sturgeon | Mar 1974 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos | May 1981 | A |
4291420 | Reul | Sep 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4425908 | Simon | Jan 1984 | A |
4470157 | Love | Sep 1984 | A |
4501030 | Lane | Feb 1985 | A |
4574803 | Storz | Mar 1986 | A |
4580568 | Gianturco | Apr 1986 | A |
4665906 | Jervis | May 1987 | A |
4681908 | Broderick et al. | Jul 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4797901 | Baykut | Jan 1989 | A |
4819751 | Shimada et al. | Apr 1989 | A |
4834755 | Silvestrini et al. | May 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4872874 | Taheri | Oct 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4909252 | Goldberger | Mar 1990 | A |
4917102 | Miller et al. | Apr 1990 | A |
4922905 | Strecker | May 1990 | A |
4954126 | Wallsten | Sep 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5217483 | Tower | Jul 1993 | A |
5232445 | Bonzel | Aug 1993 | A |
5272909 | Nguyen et al. | Dec 1993 | A |
5295958 | Shturman | Mar 1994 | A |
5327774 | Nguyen et al. | Jul 1994 | A |
5332402 | Teitelbaum et al. | Jul 1994 | A |
5350398 | Pavcnik et al. | Sep 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415633 | Lazarus et al. | May 1995 | A |
5431676 | Dubrul et al. | Jul 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5449384 | Johnson | Sep 1995 | A |
5480424 | Cox | Jan 1996 | A |
5489294 | McVenes et al. | Feb 1996 | A |
5489297 | Duran | Feb 1996 | A |
5496346 | Horzewski et al. | Mar 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5507767 | Maeda et al. | Apr 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545211 | An et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5580922 | Park et al. | Dec 1996 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5645559 | Hachtman et al. | Jul 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5674277 | Freitag | Oct 1997 | A |
5695498 | Tower | Dec 1997 | A |
5702368 | Stevens et al. | Dec 1997 | A |
5713953 | Vallana et al. | Feb 1998 | A |
5716417 | Girard et al. | Feb 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5766151 | Valley et al. | Jun 1998 | A |
5782809 | Umeno et al. | Jul 1998 | A |
5800456 | Maeda et al. | Sep 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5824041 | Lenker | Oct 1998 | A |
5824043 | Cottone, Jr. | Oct 1998 | A |
5824053 | Khosravi et al. | Oct 1998 | A |
5824056 | Rosenberg | Oct 1998 | A |
5824061 | Quijano et al. | Oct 1998 | A |
5824064 | Taheri | Oct 1998 | A |
5843158 | Lenker et al. | Dec 1998 | A |
5851232 | Lois | Dec 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5861028 | Angell | Jan 1999 | A |
5876448 | Thompson et al. | Mar 1999 | A |
5891191 | Stinson | Apr 1999 | A |
5906619 | Olson et al. | May 1999 | A |
5913842 | Boyd et al. | Jun 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5984957 | Laptewicz, Jr. et al. | Nov 1999 | A |
5997573 | Quijano et al. | Dec 1999 | A |
6022370 | Tower | Feb 2000 | A |
6027525 | Suh et al. | Feb 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6042589 | Marianne | Mar 2000 | A |
6042598 | Tsugita et al. | Mar 2000 | A |
6042607 | Williamson, IV | Mar 2000 | A |
6051104 | Jang | Apr 2000 | A |
6059809 | Amor et al. | May 2000 | A |
6110201 | Quijano et al. | Aug 2000 | A |
6146366 | Schachar | Nov 2000 | A |
6159239 | Greenhalgh | Dec 2000 | A |
6162208 | Hipps | Dec 2000 | A |
6162245 | Jayaraman | Dec 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6200336 | Pavcnik et al. | Mar 2001 | B1 |
6203550 | Olson | Mar 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6218662 | Tchakarov et al. | Apr 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6241757 | An et al. | Jun 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6248116 | Chevilon | Jun 2001 | B1 |
6258114 | Konya et al. | Jul 2001 | B1 |
6258120 | McKenzie et al. | Jul 2001 | B1 |
6277555 | Duran et al. | Aug 2001 | B1 |
6299637 | Shaolia et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6309382 | Garrison et al. | Oct 2001 | B1 |
6309417 | Spence et al. | Oct 2001 | B1 |
6338735 | Stevens | Jan 2002 | B1 |
6348063 | Yassour et al. | Feb 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6352708 | Duran et al. | Mar 2002 | B1 |
6371970 | Khosravi et al. | Apr 2002 | B1 |
6371983 | Lane | Apr 2002 | B1 |
6379383 | Palmaz et al. | Apr 2002 | B1 |
6380457 | Yurek et al. | Apr 2002 | B1 |
6398807 | Chouinard et al. | Jun 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468303 | Amplatz et al. | Oct 2002 | B1 |
6475239 | Campbell et al. | Nov 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6494909 | Greenhalgh | Dec 2002 | B2 |
6503272 | Duerig et al. | Jan 2003 | B2 |
6508833 | Pavcnik et al. | Jan 2003 | B2 |
6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
6530949 | Konya et al. | Mar 2003 | B2 |
6530952 | Vesely | Mar 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6562058 | Seguin et al. | May 2003 | B2 |
6569196 | Vesely | May 2003 | B1 |
6585758 | Chouinard et al. | Jul 2003 | B1 |
6592546 | Barbut et al. | Jul 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6613077 | Gilligan et al. | Sep 2003 | B2 |
6622604 | Chouinard et al. | Sep 2003 | B1 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6652571 | White et al. | Nov 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6656213 | Solem | Dec 2003 | B2 |
6663663 | Kim et al. | Dec 2003 | B2 |
6669724 | Park et al. | Dec 2003 | B2 |
6673089 | Yassour et al. | Jan 2004 | B1 |
6673109 | Cox | Jan 2004 | B2 |
6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
6682558 | Tu et al. | Jan 2004 | B2 |
6682559 | Myers et al. | Jan 2004 | B2 |
6685739 | DiMatteo et al. | Feb 2004 | B2 |
6689144 | Gerberding | Feb 2004 | B2 |
6689164 | Seguin | Feb 2004 | B1 |
6692512 | Jang | Feb 2004 | B2 |
6692513 | Streeter et al. | Feb 2004 | B2 |
6695878 | McGuckin, Jr. et al. | Feb 2004 | B2 |
6702851 | Chinn et al. | Mar 2004 | B1 |
6719789 | Cox | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6730377 | Wang | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6736846 | Cox | May 2004 | B2 |
6752828 | Thornton | Jun 2004 | B2 |
6758855 | Fulton, III et al. | Jul 2004 | B2 |
6769434 | Liddicoat et al. | Aug 2004 | B2 |
6786925 | Schoon | Sep 2004 | B1 |
6790229 | Berreklouw | Sep 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6792979 | Konya et al. | Sep 2004 | B2 |
6797002 | Spence | Sep 2004 | B2 |
6821297 | Snyders | Nov 2004 | B2 |
6830575 | Stenzel et al. | Dec 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6830585 | Artof | Dec 2004 | B1 |
6846325 | Liddicoat | Jan 2005 | B2 |
6866650 | Stevens | Mar 2005 | B2 |
6872223 | Roberts | Mar 2005 | B2 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6883522 | Spence et al. | Apr 2005 | B2 |
6887266 | Williams et al. | May 2005 | B2 |
6890330 | Streeter et al. | May 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6896690 | Lambrecht et al. | May 2005 | B1 |
6908481 | Cribier | Jun 2005 | B2 |
6913600 | Valley et al. | Jul 2005 | B2 |
6929653 | Streeter | Aug 2005 | B2 |
6936066 | Palmaz et al. | Aug 2005 | B2 |
6939365 | Fogarty et al. | Sep 2005 | B1 |
6951571 | Srivastava | Oct 2005 | B1 |
6974474 | Pavcnik et al. | Dec 2005 | B2 |
6974476 | McGuckin et al. | Dec 2005 | B2 |
6986742 | Hart et al. | Jan 2006 | B2 |
6989027 | Allen et al. | Jan 2006 | B2 |
6989028 | Lashinski et al. | Jan 2006 | B2 |
6991649 | Sievers | Jan 2006 | B2 |
7018401 | Hyodoh et al. | Mar 2006 | B1 |
7041128 | McGuckin, Jr. et al. | May 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7048014 | Hyodoh et al. | May 2006 | B2 |
7097659 | Woolfson et al. | Aug 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7105016 | Shui et al. | Sep 2006 | B2 |
7115141 | Menz et al. | Oct 2006 | B2 |
7128759 | Osborne et al. | Oct 2006 | B2 |
7147663 | Berg et al. | Dec 2006 | B1 |
7153324 | Case et al. | Dec 2006 | B2 |
7160319 | Chouinard et al. | Jan 2007 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7186265 | Sharkawy et al. | Mar 2007 | B2 |
7195641 | Palmaz et al. | Mar 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201761 | Woolfson et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7252682 | Seguin | Aug 2007 | B2 |
7300457 | Palmaz | Nov 2007 | B2 |
7300463 | Liddicoat | Nov 2007 | B2 |
7316706 | Bloom et al. | Jan 2008 | B2 |
7329278 | Seguin | Feb 2008 | B2 |
7335218 | Wilson et al. | Feb 2008 | B2 |
7338520 | Bailey et al. | Mar 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7377938 | Sarac et al. | May 2008 | B2 |
7381218 | Shreck | Jun 2008 | B2 |
7384411 | Condado | Jun 2008 | B1 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7470284 | Lambrecht et al. | Dec 2008 | B2 |
7481838 | Carpentier et al. | Jan 2009 | B2 |
7544206 | Cohn et al. | Jun 2009 | B2 |
7547322 | Sarac et al. | Jun 2009 | B2 |
7556646 | Yang et al. | Jul 2009 | B2 |
7806919 | Bloom et al. | Oct 2010 | B2 |
8034102 | Bulman-Fleming | Oct 2011 | B2 |
20010002445 | Vesely | Mar 2001 | A1 |
20010000188 | Lenker et al. | Apr 2001 | A1 |
20010001314 | Davison et al. | May 2001 | A1 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010010017 | Letac et al. | Jul 2001 | A1 |
20010011189 | Drasler et al. | Aug 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010025196 | Chinn et al. | Sep 2001 | A1 |
20010032013 | Marton | Oct 2001 | A1 |
20010039450 | Pavcnik et al. | Nov 2001 | A1 |
20010041928 | Pavcnik et al. | Nov 2001 | A1 |
20010044647 | Pinchuk et al. | Nov 2001 | A1 |
20020010508 | Chobotov | Jan 2002 | A1 |
20020029014 | Jayaraman | Mar 2002 | A1 |
20020032480 | Spence et al. | Mar 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020035396 | Heath | Mar 2002 | A1 |
20020042650 | Vardi et al. | Apr 2002 | A1 |
20020052651 | Myers et al. | May 2002 | A1 |
20020058995 | Stevens | May 2002 | A1 |
20020072789 | Hackett et al. | Jun 2002 | A1 |
20020095209 | Zadno-Azizi et al. | Jul 2002 | A1 |
20020099439 | Schwartz et al. | Jul 2002 | A1 |
20020103533 | Langberg et al. | Aug 2002 | A1 |
20020107565 | Greenhalgh | Aug 2002 | A1 |
20020111674 | Chouinard et al. | Aug 2002 | A1 |
20020123802 | Snyders | Sep 2002 | A1 |
20020133183 | Lentz et al. | Sep 2002 | A1 |
20020138138 | Yang | Sep 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020161392 | Dubrul | Oct 2002 | A1 |
20020161394 | Macoviak et al. | Oct 2002 | A1 |
20020193871 | Beyersdorf et al. | Dec 2002 | A1 |
20030014104 | Cribier | Jan 2003 | A1 |
20030023300 | Bailey et al. | Jan 2003 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030028247 | Cali | Feb 2003 | A1 |
20030036791 | Bonhoeffer et al. | Feb 2003 | A1 |
20030040771 | Hyodoh et al. | Feb 2003 | A1 |
20030040772 | Hyodoh et al. | Feb 2003 | A1 |
20030040792 | Gabbay | Feb 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030055495 | Pease et al. | Mar 2003 | A1 |
20030065386 | Weadock | Apr 2003 | A1 |
20030069492 | Abrams et al. | Apr 2003 | A1 |
20030109924 | Cribier | Jun 2003 | A1 |
20030125795 | Pavcnik et al. | Jul 2003 | A1 |
20030130726 | Thorpe et al. | Jul 2003 | A1 |
20030130729 | Paniagua et al. | Jul 2003 | A1 |
20030139804 | Hankh et al. | Jul 2003 | A1 |
20030149475 | Hyodoh et al. | Aug 2003 | A1 |
20030149476 | Damm et al. | Aug 2003 | A1 |
20030149478 | Figulla et al. | Aug 2003 | A1 |
20030153974 | Spenser et al. | Aug 2003 | A1 |
20030181850 | Diamond et al. | Sep 2003 | A1 |
20030191519 | Lombardi et al. | Oct 2003 | A1 |
20030199913 | Dubrul et al. | Oct 2003 | A1 |
20030199963 | Tower et al. | Oct 2003 | A1 |
20030199971 | Tower et al. | Oct 2003 | A1 |
20030212410 | Stenzel et al. | Nov 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20030225445 | Derus et al. | Dec 2003 | A1 |
20040019374 | Hojeibane et al. | Jan 2004 | A1 |
20040034411 | Quijano et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040049224 | Buehlmann et al. | Mar 2004 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20040049266 | Anduiza et al. | Mar 2004 | A1 |
20040082904 | Houde et al. | Apr 2004 | A1 |
20040088045 | Cox | May 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040092989 | Wilson et al. | May 2004 | A1 |
20040093005 | Durcan | May 2004 | A1 |
20040093060 | Sequin et al. | May 2004 | A1 |
20040093075 | Kuehn | May 2004 | A1 |
20040097788 | Mourles et al. | May 2004 | A1 |
20040098112 | DiMatteo et al. | May 2004 | A1 |
20040106976 | Bailey et al. | Jun 2004 | A1 |
20040106990 | Spence et al. | Jun 2004 | A1 |
20040111096 | Tu et al. | Jun 2004 | A1 |
20040116951 | Rosengart | Jun 2004 | A1 |
20040117004 | Osborne et al. | Jun 2004 | A1 |
20040122468 | Yodfat et al. | Jun 2004 | A1 |
20040122514 | Fogarty et al. | Jun 2004 | A1 |
20040122516 | Fogarty | Jun 2004 | A1 |
20040127979 | Wilson | Jul 2004 | A1 |
20040138742 | Myers et al. | Jul 2004 | A1 |
20040138743 | Myers et al. | Jul 2004 | A1 |
20040153146 | Lashinski et al. | Aug 2004 | A1 |
20040167573 | Williamson | Aug 2004 | A1 |
20040167620 | Ortiz | Aug 2004 | A1 |
20040186563 | Iobbi | Sep 2004 | A1 |
20040193261 | Berreklouw | Sep 2004 | A1 |
20040210240 | Saint | Oct 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215333 | Duran | Oct 2004 | A1 |
20040215339 | Drasler et al. | Oct 2004 | A1 |
20040225353 | McGuckin, Jr. | Nov 2004 | A1 |
20040225354 | Allen | Nov 2004 | A1 |
20040254636 | Flagle et al. | Dec 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20040260394 | Douk | Dec 2004 | A1 |
20040267357 | Allen et al. | Dec 2004 | A1 |
20050010246 | Streeter | Jan 2005 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050010287 | Macoviak | Jan 2005 | A1 |
20050015112 | Cohn et al. | Jan 2005 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050043790 | Seguin | Feb 2005 | A1 |
20050049692 | Numamoto | Mar 2005 | A1 |
20050049696 | Siess | Mar 2005 | A1 |
20050055088 | Liddicoat et al. | Mar 2005 | A1 |
20050060029 | Le | Mar 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050075584 | Cali | Apr 2005 | A1 |
20050075712 | Biancucci | Apr 2005 | A1 |
20050075717 | Nguyen | Apr 2005 | A1 |
20050075719 | Bergheim | Apr 2005 | A1 |
20050075724 | Svanidze | Apr 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050075730 | Myers | Apr 2005 | A1 |
20050075731 | Artof | Apr 2005 | A1 |
20050085841 | Eversull et al. | Apr 2005 | A1 |
20050085842 | Eversull et al. | Apr 2005 | A1 |
20050085843 | Opolski et al. | Apr 2005 | A1 |
20050085890 | Rasmussen et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050096568 | Kato | May 2005 | A1 |
20050096692 | Linder et al. | May 2005 | A1 |
20050096724 | Stenzel et al. | May 2005 | A1 |
20050096734 | Majercak et al. | May 2005 | A1 |
20050096735 | Hojeibane et al. | May 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050113910 | Paniagua | May 2005 | A1 |
20050119688 | Berheim | Jun 2005 | A1 |
20050131438 | Cohn | Jun 2005 | A1 |
20050137686 | Salahieh | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137692 | Haug | Jun 2005 | A1 |
20050137695 | Salahieh | Jun 2005 | A1 |
20050137701 | Salahieh | Jun 2005 | A1 |
20050143807 | Pavcnik et al. | Jun 2005 | A1 |
20050143809 | Salahieh | Jun 2005 | A1 |
20050148997 | Valley et al. | Jul 2005 | A1 |
20050149181 | Eberhardt | Jul 2005 | A1 |
20050165477 | Anduiza et al. | Jul 2005 | A1 |
20050187616 | Realyvasquez | Aug 2005 | A1 |
20050197695 | Stacchino et al. | Sep 2005 | A1 |
20050203549 | Realyvasquez | Sep 2005 | A1 |
20050203605 | Dolan | Sep 2005 | A1 |
20050203618 | Sharkawy | Sep 2005 | A1 |
20050222674 | Paine | Oct 2005 | A1 |
20050228495 | Macoviak | Oct 2005 | A1 |
20050234546 | Nugent | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050240263 | Fogarty et al. | Oct 2005 | A1 |
20050261759 | Lambrecht et al. | Nov 2005 | A1 |
20050283962 | Boudjemline | Dec 2005 | A1 |
20060004439 | Spenser et al. | Jan 2006 | A1 |
20060004469 | Sokel | Jan 2006 | A1 |
20060009841 | McGuckin et al. | Jan 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058775 | Stevens et al. | Mar 2006 | A1 |
20060089711 | Dolan | Apr 2006 | A1 |
20060100685 | Seguin et al. | May 2006 | A1 |
20060116757 | Lashinski et al. | Jun 2006 | A1 |
20060135964 | Vesely | Jun 2006 | A1 |
20060142848 | Gabbay | Jun 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060167474 | Bloom et al. | Jul 2006 | A1 |
20060173537 | Yang | Aug 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060206192 | Tower et al. | Sep 2006 | A1 |
20060206202 | Bonhoefer et al. | Sep 2006 | A1 |
20060212111 | Case et al. | Sep 2006 | A1 |
20060247763 | Slater | Nov 2006 | A1 |
20060259134 | Schwammenthal et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060271166 | Thill et al. | Nov 2006 | A1 |
20060271175 | Woolfson et al. | Nov 2006 | A1 |
20060276874 | Wilson et al. | Dec 2006 | A1 |
20060276882 | Case et al. | Dec 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20070005129 | Damm et al. | Jan 2007 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010878 | Raffiee et al. | Jan 2007 | A1 |
20070016286 | Case et al. | Jan 2007 | A1 |
20070027518 | Herrmann et al. | Feb 2007 | A1 |
20070027533 | Douk | Feb 2007 | A1 |
20070038295 | Case et al. | Feb 2007 | A1 |
20070043431 | Melsheimer | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070073392 | Heyninck-Janitz | Mar 2007 | A1 |
20070078509 | Lotfy et al. | Apr 2007 | A1 |
20070078510 | Ryan | Apr 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070093869 | Bloom et al. | Apr 2007 | A1 |
20070100439 | Cangialosi | May 2007 | A1 |
20070100440 | Figulla | May 2007 | A1 |
20070100449 | O'Neil et al. | May 2007 | A1 |
20070112415 | Bartlett | May 2007 | A1 |
20070162102 | Ryan et al. | Jul 2007 | A1 |
20070162113 | Sharkawy et al. | Jul 2007 | A1 |
20070185513 | Woolfson et al. | Aug 2007 | A1 |
20070203391 | Bloom et al. | Aug 2007 | A1 |
20070225681 | House | Sep 2007 | A1 |
20070232898 | Huynh et al. | Oct 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070233237 | Krivoruchko | Oct 2007 | A1 |
20070233238 | Huynh et al. | Oct 2007 | A1 |
20070238979 | Huynh et al. | Oct 2007 | A1 |
20070239254 | Marchand et al. | Oct 2007 | A1 |
20070239265 | Birdsall | Oct 2007 | A1 |
20070239266 | Birdsall | Oct 2007 | A1 |
20070239269 | Dolan et al. | Oct 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244544 | Birdsall et al. | Oct 2007 | A1 |
20070244545 | Birdsall et al. | Oct 2007 | A1 |
20070244546 | Francis | Oct 2007 | A1 |
20070244553 | Rafiee et al. | Oct 2007 | A1 |
20070244554 | Rafiee et al. | Oct 2007 | A1 |
20070244555 | Rafiee et al. | Oct 2007 | A1 |
20070244556 | Rafiee et al. | Oct 2007 | A1 |
20070244557 | Rafiee et al. | Oct 2007 | A1 |
20070250160 | Rafiee | Oct 2007 | A1 |
20070255394 | Ryan | Nov 2007 | A1 |
20070255396 | Douk et al. | Nov 2007 | A1 |
20070288000 | Bonan | Dec 2007 | A1 |
20080004696 | Vesely | Jan 2008 | A1 |
20080009940 | Cribier | Jan 2008 | A1 |
20080015671 | Bonhoeffer | Jan 2008 | A1 |
20080021552 | Gabbay | Jan 2008 | A1 |
20080039934 | Styrc | Feb 2008 | A1 |
20080048656 | Tan | Feb 2008 | A1 |
20080065001 | Marchand et al. | Mar 2008 | A1 |
20080065206 | Liddicoat | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071368 | Tuval et al. | Mar 2008 | A1 |
20080077234 | Styrc | Mar 2008 | A1 |
20080082165 | Wilson et al. | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080133003 | Seguin et al. | Jun 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147105 | Wilson et al. | Jun 2008 | A1 |
20080147180 | Ghione et al. | Jun 2008 | A1 |
20080147181 | Ghione et al. | Jun 2008 | A1 |
20080147182 | Righini et al. | Jun 2008 | A1 |
20080154355 | Benichow et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080161910 | Revuelta et al. | Jul 2008 | A1 |
20080161911 | Revuelta et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080188928 | Salahieh et al. | Aug 2008 | A1 |
20080215143 | Seguin et al. | Sep 2008 | A1 |
20080215144 | Ryan et al. | Sep 2008 | A1 |
20080228254 | Ryan | Sep 2008 | A1 |
20080228263 | Ryan | Sep 2008 | A1 |
20080234797 | Stryc | Sep 2008 | A1 |
20080243246 | Ryan et al. | Oct 2008 | A1 |
20080255651 | Dwork | Oct 2008 | A1 |
20080255660 | Guyenot | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080262593 | Ryan et al. | Oct 2008 | A1 |
20080269878 | Iobbi | Oct 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090012600 | Styrc et al. | Jan 2009 | A1 |
20090048656 | Wen | Feb 2009 | A1 |
20090054976 | Tuval et al. | Feb 2009 | A1 |
20090069886 | Suri et al. | Mar 2009 | A1 |
20090069887 | Righini et al. | Mar 2009 | A1 |
20090069889 | Suri et al. | Mar 2009 | A1 |
20090082858 | Nugent et al. | Mar 2009 | A1 |
20090085900 | Weiner | Apr 2009 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090164004 | Cohn | Jun 2009 | A1 |
20090171447 | VonSegesser et al. | Jul 2009 | A1 |
20090192585 | Bloom et al. | Jul 2009 | A1 |
20090192586 | Tabor et al. | Jul 2009 | A1 |
20090192591 | Ryan et al. | Jul 2009 | A1 |
20090198316 | Laske et al. | Aug 2009 | A1 |
20090216310 | Straubinger et al. | Aug 2009 | A1 |
20090216312 | Straubinger et al. | Aug 2009 | A1 |
20090216313 | Straubinger et al. | Aug 2009 | A1 |
20090222082 | Lock et al. | Sep 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090240264 | Tuval et al. | Sep 2009 | A1 |
20090240320 | Tuval | Sep 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20100036479 | Hill et al. | Feb 2010 | A1 |
20100094411 | Tuval et al. | Apr 2010 | A1 |
20100100167 | Bortlein et al. | Apr 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100137979 | Tuval et al. | Jun 2010 | A1 |
20100161045 | Righini | Jun 2010 | A1 |
20100198346 | Keogh et al. | Aug 2010 | A1 |
20100234940 | Dolan | Sep 2010 | A1 |
20100256723 | Murray | Oct 2010 | A1 |
Number | Date | Country |
---|---|---|
2007100074433 | Aug 2007 | CN |
3640745 | Jun 1987 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
1057460 | Jun 2000 | EP |
1255510 | Nov 2002 | EP |
1469797 | Nov 2005 | EP |
2788217 | Dec 1999 | FR |
2815844 | May 2000 | FR |
2056023 | Mar 1981 | GB |
2433700 | Apr 2007 | GB |
1271508 | Nov 1986 | SU |
WO9529640 | Nov 1995 | WO |
WO0047136 | Aug 2000 | WO |
WO0135870 | May 2001 | WO |
WO0149213 | Jul 2001 | WO |
WO0154625 | Aug 2001 | WO |
WO0162189 | Aug 2001 | WO |
WO0164137 | Sep 2001 | WO |
WO0222054 | Mar 2002 | WO |
WO0236048 | May 2002 | WO |
WO03003943 | Jan 2003 | WO |
WO03003949 | Jan 2003 | WO |
WO03011195 | Feb 2003 | WO |
WO2003047468 | Jun 2003 | WO |
WO04019825 | Mar 2004 | WO |
WO04089250 | Oct 2004 | WO |
WO05002466 | Jan 2005 | WO |
WO05004753 | Jan 2005 | WO |
WO05046528 | May 2005 | WO |
WO06026371 | Mar 2006 | WO |
WO06070372 | Jul 2006 | WO |
WO08047354 | Apr 2008 | WO |
WO2008070797 | Jun 2008 | WO |
WO08138584 | Nov 2008 | WO |
WO08150529 | Dec 2008 | WO |
WO09002548 | Dec 2008 | WO |
WO09029199 | Mar 2009 | WO |
WO09042196 | Apr 2009 | WO |
WO09045338 | Apr 2009 | WO |
WO09061389 | May 2009 | WO |
WO09091509 | Jul 2009 | WO |
WO09111241 | Sep 2009 | WO |
Entry |
---|
Andersen, H.R. et al, “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” Euro. Heart J. (1992) 13:704-708. |
Babaliaros, et al., “State of the Art Percutaneous Intervention for the Treatment of Valvular Heart Disease: A Review of the Current Technologies and Ongoing Research in the Field of Percutaneous Heart Valve Replacement and Repair,” Cardiology 2007; 107:87-96. |
Bailey, “Percutaneous Expandable Prosthetic Valves,” In: Topol EJ, ed. Textbook of Interventional Cardiology. Volume II. Second edition. WB Saunders, Philadelphia, 1994:1268-1276. |
Block, et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, vol. 7 (2005) pp. 108-113. |
Bonhoeffer, et al, “Percutaneous Insertion of the Pulmonary Valve,” Journal of the American College of Cardiology (United States), May 15, 2002, pp. 1664-1669. |
Bonhoeffer, et al, “Percutaneous Replacement of Pulmonary Valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Lancet (England), Oct. 21, 2000, pp. 1403-1405. |
Bonhoeffer, et al, “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation (United States), Aug. 15, 2000, pp. 813-816. |
Boudjemline, et al, “Images in Cardiovascular Medicine. Percutaneous Aortic Valve Replacement in Animals,” Circulation (United States), Mar. 16, 2004, 109, p. e161. |
Boudjemline, et al, “Is Percutaneous Implantation of a Bovine Venous Valve in the Inferior Vena Cava a Reliable Technique to Treat Chronic Venous Insufficiency Syndrome?” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Mar. 2004, pp. BR61-BR66. |
Boudjemline, et al, “Off-pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Hybrid Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Apr. 2005, pp. 831-837. |
Boudjemline, et al, “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart (British Cardiac Society) (England), Dec. 2001, pp. 705-706. |
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study,” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Apr. 2002, pp. BR113-BR116. |
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal 22, Sep. 2001, p. 630. |
Boudjemline, et al, “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs,” European Heart Journal (England), Jul. 2002, pp. 1045-1049. |
Boudjemline, et al, “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study,” Journal of the American College of Cardiology (United States), Mar. 17, 2004, pp. 1082-1087. |
Boudjemline, et al, “Percutaneous Valve Insertion: A New Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Mar. 2003, pp. 741-742. |
Boudjemline, et al, “Stent Implantation Combined with a Valve Replacement to Treat Degenerated Right Ventricle to Pulmonary Artery Prosthetic Conduits,” European Heart Journal 22, Sep. 2001, p. 355. |
Boudjemline, et al, “Steps Toward Percutaneous Aortic Valve Replacement,” Circulation (United States), Feb. 12, 2002, pp. 775-778. |
Boudjemline, et al, “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology (Ireland), 2001, pp. 89-93. |
Boudjemline, et al, “Transcatheter Reconstruction of the Right Heart,” Cardiology in the Young (England), Jun. 2003, pp. 308-311. |
Coats, et al, “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery (England), Apr. 2005, pp. 536-543. |
Cribier, A. et al, “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description,” Circulation (2002) 3006-3008. |
Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15 (2006) 123-129. |
Hanzel, et al., “Complications of percutaneous aortic valve replacement: experience with the Criber-Edwards™ percutaneous heart valve,” EuroIntervention Supplements (2006), 1 (Supplement A) A3-A8. |
Huber, et al., “Do Valved Stents Compromise Coronary Flow?” Eur. J. Cardiothorac. Surg. 2004;25:754-759. |
Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408. |
Khambadkone, et al, “Percutaneous Implantation of Pulmonary Valves,” Expert Review of Cardiovascular Therapy (England), Nov. 2003, pp. 541-548. |
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Early and Medium Term Results,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-375. |
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Impact of Morphology on Case Selection,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-642-IV-643. |
Lutter, et al, “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation,” The Journal of Thoracic and Cardiovascular Surgery, Apr. 2002, pp. 768-776. |
Lutter, et al, “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery (Netherlands), Dec. 2004, pp. 2199-2206. |
Ma, Ling, et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio Thoracic Surgery, 28:194-198, 2005. |
Medtech Insight, “New Frontiers in Heart Valve Disease,” vol. 7, No. 8 (2005). |
Palacios, “Percutaneous Valve Replacement and Repair, Fiction or Reality?” Journal of American College of Cardiology, vol. 44, No. 8 (2004) pp. 1662-1663. |
Pelton et al., “Medical Uses of Nitinol,” Materials Science Forum vols. 327-328, pp. 63-70 (2000). |
Rulz, “Transcathether Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, vol. 26, No. 3 (2005). |
Saliba, et al, “Treatment of Obstructions of Prosthetic Conduits by Percutaneous Implantation of Stents,” Archives des Maldies du Coeur et des Vaisseaux (France), 1999, pp. 591-596. |
Webb, et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation (2006), 113;842-850. |
Stassano et al., “Mid-term results of the valve-on-valve technique for bioprosthetic failure,” Eur. J. Cardiothorac. Surg. 2000; 18:453-457. |
Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Techol. 2000, vol. 9, pp. 287-292. |
Number | Date | Country | |
---|---|---|---|
20180161158 A1 | Jun 2018 | US |
Number | Date | Country | |
---|---|---|---|
61379115 | Sep 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13216533 | Aug 2011 | US |
Child | 15894243 | US |